SubHero Banner
Text

July 2024

Core topics in this month’s edition include:

  • Kisunla (donanemab-azbt)– new drug approval
  • Corlanor (ivabradine) – first time generic
  • Palforzia (peanut [Arachis hypogaea] allergen powder-dnfp) – expanded indication
  • Zunveyl (benzgalantamine) – new drug approval

Download PDF

Text